Caricamento...
Synergistic antiproliferative effects of arsenic trioxide (ATO) with bortezomib in mantle cell lymphoma (MCL)
Mantle cell lymphoma (MCL) is a subtype of B-cell Non-Hodgkin’s Lymphoma (NHL) and accounts for approximately 6% of all lymphomas. MCL is highly refractory to most chemotherapy including newer antibody-based therapeutic approaches, and high-grade MCL has one of the worst survival rates among NHLs. T...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3894928/ https://ncbi.nlm.nih.gov/pubmed/22965904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23317 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|